Hepatitis B infection in rural Vietnam and the implications for a National Program of Infant Immunization

被引:58
作者
Hipgrave, DB [1 ]
Van, NT
Huong, VM
Long, HT
Dat, DT
Trung, TN
Jolley, D
Maynard, JE
Biggs, BA
机构
[1] Alfred Med Res & Educ Precinct, Burnham Inst, Int Hlth Unit, Melbourne, Vic, Australia
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia
[3] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam
[4] Program Appropriate Technol, Hanoi, Vietnam
[5] Deakin Univ, Sch Hlth Sci, Burwood, Australia
关键词
D O I
10.4269/ajtmh.2003.69.288
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
To ascertain hepatitis B virus (HBV) infection rates for Vietnam, we surveyed HBV markers in two districts of Thanh Hoa province. We randomly selected 536 infants (9-less than or equal to18 months old), 228 children (4 to :5 6 years old), 219 adolescents (14 to less than or equal to 16 years old), and 596 adults (25 to less than or equal to 40 years old). On questioning, none of those surveyed had received vaccine against HBV. Hepatitis B virus surface antigen (HBsAg) and total HBV core antibody (anti-HBc) were measured in all specimens, and HBV e antigen (HBeAg) in those positive for HBsAg, and HBV surface antibody (anti-HBs) were measured in all others. Current infection (HBsAg+) rates were infants = 12.5%, children = 18.4%, adolescents = 20.5%, and adults = 18.8%. Current or previous infection (HBsAg+, anti-HBc+, or anti-HBs+) increased with age (infants = 19.6%, children = 36.4%, adolescents = 55.3%, adults = 79.2%). Rates of HBeAg among those HBsAg+ were infants = 85.1%, children = 88.1%, adolescents = 71.1%, and adults = 30.4%. The epidemiology of HBV in Vietnam resembles that of many southeast Asian nations before introduction of vaccine. Immunization of newborns will have enormous impact on HBV-related morbidity and mortality there.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 45 条
[1]
Al-Faleh FZ, 1999, J INFECTION, V38, P167, DOI 10.1016/S0163-4453(99)90245-1
[2]
THE CHANGING EPIDEMIOLOGY OF HEPATITIS-B IN THE UNITED-STATES - NEED FOR ALTERNATIVE VACCINATION STRATEGIES [J].
ALTER, MJ ;
HADLER, SC ;
MARGOLIS, HS ;
ALEXANDER, WJ ;
HU, PY ;
JUDSON, FN ;
MARES, A ;
MILLER, JK ;
MOYER, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (09) :1218-1222
[3]
REVIEW - PROTECTIVE EFFICACY OF HEPATITIS-B VACCINES IN NEONATES [J].
ANDRE, FE ;
ZUCKERMAN, AJ .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (02) :144-151
[4]
[Anonymous], 1991, MMWR Recomm Rep, V40, P1
[5]
ANZIMLT AM, 1985, NEW ZEAL MED J, V98, P529
[6]
Beasley R.P., 1984, VIRAL HEPATITIS LIVE, P209
[7]
E-ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS-B SURFACE-ANTIGEN [J].
BEASLEY, RP ;
TREPO, C ;
STEVENS, CE ;
SZMUNESS, W .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (02) :94-98
[8]
BEASLEY RP, 1981, LANCET, V2, P388
[9]
SEX DIFFERENCE IN CHRONIC HEPATITIS-B VIRUS-INFECTION - STUDIES OF SERUM HBEAG AND ALANINE AMINOTRANSFERASE LEVELS IN 10,431 ASYMPTOMATIC CHINESE HBSAG-CARRIERS [J].
CHU, CM ;
SHEEN, IS ;
LIN, SM ;
LIAW, YF .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (05) :709-713
[10]
Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand [J].
Chunsuttiwat, S ;
Biggs, BA ;
Maynard, J ;
Thamapalo, S ;
Laoboripat, S ;
Bovornsin, S ;
Charanasri, U ;
Pinyowiwat, W ;
Kunasol, P .
VACCINE, 1997, 15 (6-7) :769-774